Skip to main content
Toggle navigation
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
B
Bahlis, Nizar
Arnie Charbonneau Cancer Institute - University of Calgary
Translational Research
Location: Hall FG
Nizar Bahlis
Balakumaran, Arun
Pfizer
Future Targets and New Modalities of Therapy: ADCs and Epigenetic Regulators in Multiple Myeloma
Location: Hall FG
Arun Balakumaran
Banerjee, Rahul
Fred Hutchinson Cancer Center
Addressing unmet needs in RRMM: new therapies in development
Location: Hall FG
Rahul Banerjee
(OA-53) Functional High-Risk (FHR) Phenotype Predicts Poor Survival in Multiple Myeloma (MM) Independent of Frontline Treatment: A Secondary CIBMTR Analysis
Location: Room 701
Rahul Banerjee
Beksac, Meral
Istinye University Ankara Liv Hospital, Department of Hematology
Abstract Session 1
Location: Room 701
Meral Beksac
Berdeja, Jesus
Tennessee Oncology
Abstract Session 11
Location: Room 701
Jesus Berdeja
Bergsagel, Peter
Mayo Clinic Arizona
Ken Anderson Award
Location: Hall FG
Peter Bergsagel
Round Table discussion
Location: Hall FG
Peter Bergsagel
Bertamini, Luca
Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
(OA-23) Circulating Tumor Cells for the Staging of Multiple Myeloma: First Results of a European Pooled Analysis of 2432 Patients with Newly Diagnosed Multiple Myeloma and Plasma Cell Leukemia
Location: Room 718
Luca Bertamini
Besschetnova, Anna
Dana-Farber Cancer Institute
(OA-28) Midnolin Downregulation Promotes Myelomagenesis via Impacting Ubiquitination Independent Pathway of Protein Degradation
Location: Room 718
Anna Besschetnova
Bhasin, Manoj
Emory University
Abstract Session 2
Location: Room 718
Manoj Bhasin
Bila, Jelena
Clinic of Hematology, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade
Managing myeloma with limited resources - challenges and opportunities
Location: Delta Hotel
Jelena Bila
Blade, Joan
Hospital Clinic de Barcelona
IMWG-IMS consensus workshop summaries
Location: Hall FG
Joan Blade
Bobin, Arthur
University Hospital of Poitiers
(OA-46) Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma: Results from ISASOCUT (IFM 2022-05)
Location: Room 701
Arthur Bobin
Boise, Lawrence
Emory University
Basic Research
Location: Hall FG
Lawrence Boise
(OA-64) Evidence for Pre-Existing Myeloma Cells with a Gene Expression Pattern Associated with Resistance to BCMA CAR T Cells.
Location: Room 718
Lawrence Boise
Bolli, Niccolo
University of Milan/Policlinico Hospital
CHiP
Location: Hall FG
Niccolo Bolli
Bursey, Wendy
Juravinski Cancer Centre
9th Nursing & Allied Health Symposium: Session 1: Cellular Therapies: Building Equity of Access
Location: Room 501
Wendy Bursey
9th Nursing & Allied Health Symposium: Welcome
Location: Room 501
Wendy Bursey
